{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Sample+Collection+Blood&page=56", "query": { "intervention": "Sample Collection Blood", "page": 56 }, "page_size": 10 }, "pagination": { "page": 56, "page_size": 10, "total_count": 2816, "total_pages": 282, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Sample+Collection+Blood&page=57&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Sample+Collection+Blood&page=55&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-30T22:59:44.401Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06160791", "title": "Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hemophagocytic Lymphohistiocytoses" ], "interventions": [ { "name": "Ruxolitinib", "type": "DRUG" }, { "name": "Etoposide", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Non-interventional Imaging", "type": "PROCEDURE" }, { "name": "Research Biopsy", "type": "PROCEDURE" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Jerry Lee, MD, MSc, MPhil", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 54, "start_date": "2024-10-01", "completion_date": "2029-11-30", "has_results": false, "last_update_posted_date": "2026-09-21", "last_synced_at": "2026-10-30T22:59:44.401Z", "location_count": 4, "location_summary": "Irvine, California • Sacramento, California • San Diego, California + 1 more", "locations": [ { "city": "Irvine", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06160791" }, { "nct_id": "NCT06342440", "title": "Early Detection of Advanced Adenomas and Colorectal Cancer", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Colorectal Cancer", "Colorectal Neoplasms", "Colorectal Polyp", "Colorectal Adenocarcinoma", "Colorectal Disorders", "Colorectal Dysplasia", "Colorectal Cancer Stage I", "Colorectal Cancer Stage II", "Colorectal Cancer Stage III", "Colorectal Cancer Stage IV", "Colorectal Neoplasms Malignant", "Colorectal Serrated Adenocarcinoma", "Colorectal Adenoma With Severe Dysplasia", "Colorectal Adenoma With Mild Dysplasia", "Colorectal Adenoma With Moderate Dysplasia", "Colorectal Adenoma and Carcinoma 1", "Colorectal Adenomatous Polyp", "Colorectal Adenocarcinoma Metastatic in the Liver" ], "interventions": [ { "name": "DENEB", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "City of Hope Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2000, "start_date": "2020-03-15", "completion_date": "2028-06-18", "has_results": false, "last_update_posted_date": "2026-07-07", "last_synced_at": "2026-10-30T22:59:44.401Z", "location_count": 2, "location_summary": "Monrovia, California • San Diego, California", "locations": [ { "city": "Monrovia", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06342440" }, { "nct_id": "NCT05879250", "title": "WP1066 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Glioblastoma, IDH-Wildtype", "MGMT-Unmethylated Glioblastoma" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Radiation Therapy", "type": "RADIATION" }, { "name": "STAT3 Inhibitor WP1066", "type": "DRUG" }, { "name": "Surgical Procedure", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE", "RADIATION", "DRUG" ], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 39, "start_date": "2024-05-22", "completion_date": "2028-12-27", "has_results": false, "last_update_posted_date": "2026-07-22", "last_synced_at": "2026-10-30T22:59:44.401Z", "location_count": 2, "location_summary": "Chicago, Illinois • Warrenville, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Warrenville", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT05879250" }, { "nct_id": "NCT06349642", "title": "Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Early Stage Triple-Negative Breast Carcinoma", "Metastatic Bladder Urothelial Carcinoma", "Metastatic Cervical Carcinoma", "Metastatic Clear Cell Renal Cell Carcinoma", "Metastatic Colorectal Carcinoma", "Metastatic Endometrial Carcinoma", "Metastatic Esophageal Carcinoma", "Metastatic Liver Carcinoma", "Metastatic Lung Non-Small Cell Carcinoma", "Metastatic Malignant Skin Neoplasm", "Metastatic Malignant Solid Neoplasm", "Resectable Lung Non-Small Cell Carcinoma", "Early Stage Lung Non-Small Cell Carcinoma", "Resectable Malignant Solid Neoplasm", "Resectable Triple-Negative Breast Carcinoma", "Stage III Renal Cell Cancer AJCC v8", "Stage IV Cervical Cancer AJCC v8", "Stage IV Renal Cell Cancer AJCC v8", "Stage IV Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8", "Recurrent Cervical Carcinoma", "Recurrent Colorectal Carcinoma", "Recurrent Endometrial Carcinoma", "Recurrent Esophageal Carcinoma", "Recurrent Liver Carcinoma", "Recurrent Lung Non-Small Cell Carcinoma", "Recurrent Malignant Skin Neoplasm", "Recurrent Malignant Solid Neoplasm" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Tissue Collection", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 324, "start_date": "2024-04-24", "completion_date": "2027-05", "has_results": false, "last_update_posted_date": "2026-03-12", "last_synced_at": "2026-10-30T22:59:44.401Z", "location_count": 3, "location_summary": "Phoenix, Arizona • Jacksonville, Florida • Rochester, Minnesota", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT06349642" }, { "nct_id": "NCT04171960", "title": "Clinical Evaluation of the i-STAT TBI Test", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Traumatic Brain Injury" ], "interventions": [ { "name": "Blood draw", "type": "DIAGNOSTIC_TEST" }, { "name": "Outcome assessments", "type": "OTHER" } ], "intervention_types": [ "DIAGNOSTIC_TEST", "OTHER" ], "sponsor": "Abbott Point of Care", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1106, "start_date": "2020-07-31", "completion_date": "2023-11-29", "has_results": false, "last_update_posted_date": "2026-10-29", "last_synced_at": "2026-10-30T22:59:44.401Z", "location_count": 21, "location_summary": "San Francisco, California • Denver, Colorado • Englewood, Colorado + 17 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Englewood", "state": "Colorado" }, { "city": "Miami", "state": "Florida" }, { "city": "Carmel", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT04171960" }, { "nct_id": "NCT03970096", "title": "Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acute Leukemia", "Acute Lymphoblastic Leukemia", "Acute Myeloid Leukemia", "Myelodysplastic Syndrome", "Myeloproliferative Neoplasm" ], "interventions": [ { "name": "Total-Body Irradiation", "type": "RADIATION" }, { "name": "Thiotepa", "type": "DRUG" }, { "name": "Fludarabine", "type": "DRUG" }, { "name": "Tacrolimus", "type": "DRUG" }, { "name": "Allogeneic CD34+-enriched and CD45RA-depleted PBSCs", "type": "BIOLOGICAL" }, { "name": "Methotrexate", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Peripheral Blood Stem Cell", "type": "BIOLOGICAL" }, { "name": "Cyclosporine", "type": "DRUG" }, { "name": "Sirolimus", "type": "DRUG" }, { "name": "Busulfan", "type": "DRUG" }, { "name": "Bone Marrow Aspiration and Biopsy", "type": "PROCEDURE" }, { "name": "Echocardiography", "type": "PROCEDURE" }, { "name": "Multigated Acquisition Scan", "type": "PROCEDURE" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" } ], "intervention_types": [ "RADIATION", "DRUG", "BIOLOGICAL", "PROCEDURE" ], "sponsor": "Fred Hutchinson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "60 Years", "sex": "ALL", "summary": "1 Year to 60 Years" }, "enrollment_count": 120, "start_date": "2019-11-19", "completion_date": "2030-12-31", "has_results": false, "last_update_posted_date": "2026-10-20", "last_synced_at": "2026-10-30T22:59:44.401Z", "location_count": 3, "location_summary": "Tampa, Florida • Pittsburgh, Pennsylvania • Seattle, Washington", "locations": [ { "city": "Tampa", "state": "Florida" }, { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT03970096" }, { "nct_id": "NCT02398708", "title": "Comparison of Gut Microbiota, Inflammation and Symptoms Following Allogeneic HSCT", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Graft vs Host Disease", "Graft Versus Host Disease", "Hematopoietic Stem Cell Transplantation", "Peripheral Blood Stem Cell Transplantation" ], "interventions": [ { "name": "Questionnaires", "type": "OTHER" }, { "name": "Blood Sample", "type": "OTHER" }, { "name": "Stool Sample", "type": "OTHER" }, { "name": "Clinical data", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 38, "start_date": "2015-05", "completion_date": "2016-04", "has_results": false, "last_update_posted_date": "2019-01-25", "last_synced_at": "2026-10-30T22:59:44.401Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02398708" }, { "nct_id": "NCT00436189", "title": "Assess Cancer in Ovarian Tumors With Biomarkers.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Ovarian Tumor" ], "interventions": [ { "name": "Blood Draw", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Ciphergen Biosystems", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 1000, "start_date": "2007-02", "completion_date": "2008-04", "has_results": false, "last_update_posted_date": "2008-04-30", "last_synced_at": "2026-10-30T22:59:44.401Z", "location_count": 18, "location_summary": "Hoover, Alabama • Phoenix, Arizona • Newport Beach, California + 14 more", "locations": [ { "city": "Hoover", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Newport Beach", "state": "California" }, { "city": "Vista", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00436189" }, { "nct_id": "NCT06067503", "title": "Biomarkers to Detect Endocrine Therapy Resistance", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Metastatic Cancer", "Breast Cancer", "Lobular Breast Carcinoma" ], "interventions": [ { "name": "18F-fluorofuranylnorprogesterone", "type": "DRUG" }, { "name": "Liquid Biopsy", "type": "DEVICE" }, { "name": "Positron Emission Tomography/Computed Tomography", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "University of Wisconsin, Madison", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 8, "start_date": "2024-04-30", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-08-25", "last_synced_at": "2026-10-30T22:59:44.401Z", "location_count": 1, "location_summary": "Madison, Wisconsin", "locations": [ { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT06067503" }, { "nct_id": "NCT06956391", "title": "Ultralow Dose PET Imaging of 18F-FDG Uptake", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Healthy Volunteer", "Cancer" ], "interventions": [ { "name": "18F-FDG", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Akiva Mintz", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "18 Years to 120 Years" }, "enrollment_count": 200, "start_date": "2025-05-12", "completion_date": "2030-06-30", "has_results": false, "last_update_posted_date": "2025-06-04", "last_synced_at": "2026-10-30T22:59:44.401Z", "location_count": 1, "location_summary": "Englewood, New Jersey", "locations": [ { "city": "Englewood", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT06956391" } ] }